BCYC
Bicycle Therapeutics plc
Latest News for BCYC
Analysts fell to the sidelines weighing in on Edwards Lifesciences (EW – Research Report), Bicycle Therapeutics (BCYC – Research Report) and Envist......
In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Bicycle Therapeutics, with a price target of $44.00. The company’......
In a report released today, Peter Lawson from Barclays maintained a Buy rating on Bicycle Therapeutics, with a price target of $15.00. The company’......
TD Cowen analyst Tara Bancroft maintained a Buy rating on Bicycle Therapeutics today. The company’s shares opened today at $8.18. According to TipR......
News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCYC | $6.32 | +2.4% | 284.41K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicycle Therapeutics plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW